ask="32.00"
ask_size="300"
average_daily_volume="219168"
bid="20.15"
bid_size="100"
book_value="3.79"
change="+1.28"
change_from_200_day_moving_average="5.66"
change_from_50_day_moving_average="3.33"
change_from_52_week_high="-1.00"
change_From_52_week_low="16.68"
change_in_percent="+4.34%"
close="30.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="15631000"
high="31.38"
high_52_weeks="31.80"
last_trade_date="2/24/2017"
last_trade_price="30.80"
last_trade_size="3142"
last_trade_time="4:00pm"
low="28.40"
low_52_weeks="14.12"
market_capitalization="660.11M"
moving_average_200_day="25.14"
moving_average_50_day="27.47"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="29.26"
pe_ratio="N/A"
peg_ratio="-0.21"
percent_change_from_200_day_moving_average="+22.52%"
percent_change_from_50_day_moving_average="+12.14%"
percent_change_from_52_week_high="-3.14%"
percent_change_from_52_week_low="+118.13%"
previous_close="29.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.80"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="334704"
weeks_range_52="14.12 - 31.80"
